kingjacob
Re:I should have loved biology
on Thursday November 19, 2020 @01:41AM (#25146862)
A good place to start would be to see if there's anything on NCBI Bookshelf, and then search pubmed for recent review articles. And then you can drill down further using their citations.
Re:Man Who Stole Plane Near Seattle Raises Troubling Security Question
on Sunday August 12, 2018 @02:42PM (#17745762)
No one says that outright but poverty and violent extremism are pretty closely linked. Its not the only factor ofc, and youll always have outliers, but comfortable people with things worth losing are less likely to do something to endanger that.
Re:How Duolingo achieved a 50:50 gender ratio for new software enginee...
on Sunday January 21, 2018 @04:06PM (#16200040)
Sidebar: Do any software co’s complaining about a lack of quality female engineering talent have real apprenticeship programs like Parker Hannifin or Chevron?
Re:Freelancer.com has ruined my life
on Saturday November 04, 2017 @04:35PM (#15626784)
Might be relevant as an decentralized alternative https://ethlance.com/
Re:“Anti-perks”: what our startup doesn't want in our office
on Monday October 02, 2017 @02:52PM (#15386740)
Payroll tax. And cutting perks is easier than cutting salaries.
Re:Evercoin: A cryptocurrency exchange platform
on Monday August 14, 2017 @05:13PM (#15012967)
There are, see Etherdelta. And also projects like 0xproject.com are working on going entirely trustless.
Re:Synthetic biology startup Lygos raises $13M to make cleaner chemicals
on Tuesday December 13, 2016 @05:44PM (#13171935)
Alot of companies do exactly that. Using systems like: http://www.tapbiosystems.com/
But it's not cost effective when producing millions of liters.
Re:When antibiotics failed a severely ill patient, a virus saved him
on Thursday December 08, 2016 @11:43AM (#13131595)
It is. But technically they are correct.
If you just handed out phage freely, as you do abx, bacteria will "eventually" evolve resistance to phage....at a 2-3 orders slower rate, but it will eventually happen.
Of course, the solution is easy, you don't develop a phage therapy like you would an antibiotic, but rather like a constantly updating flu vaccine.
4 Reasons Why Todays PostDocs Are Tomorrow’s CEOs
Afineur Brings Civet Coffee ('Kopi Luwak') Without the Civet
You're invited to the synb.io demo day
Defining Synthetic Biology for Startups
Early Deadline closing to apply for SynBio axlr
Re:Why are Researchers Averse to Risk?
on Friday March 14, 2014 @03:49PM (#7401313)
Why are researchers, who are supposed to be pushing the boundaries of what is possible, so averse to taking risk? or failing?